MD, PhD, medical oncology resident @uzleuven @KU_Leuven - passionate about biomarkers in clear-cell renal cell carcinoma 🇧🇪

Leuven
Joined April 2021
#PhDone! 👩‍🎓 Last week, I successfully defended my PhD on response prediction for systemic therapies in clear-cell RCC. Incredibly grateful for the support of my supervisors professors Benoit Beuselinck, @AbhishekDGarg and @MaartenAlbersen!
4
1
15
484
Thanks as well to my jury members professors Els Wauters @ewauters, Jeroen Dekervel @JDekervel, Yann Vano and Henrik Heiland @MILOLab2, for their constructive feedback and insightful questions!
1
4
292
Finally, thanks to all my colleagues, family and friends who helped and supported me along the way. After this amazing journey at @KU_Leuven @Onco_KULeuven, excited for my final 2 years of medical oncology training at @UZLeuven!
1
74
⚡️ On @NatureMedicine - A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma #KidneyCancer #Immunotherapy @OncoAlert @OncLive nature.com/articles/s41591-0…
1
9
36
3,594
GU Research Digest for the week of May 18 - 25: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!
8
18
2,374
Lisa Kinget retweeted
Cell Stress and Immunity Lab - Heritable and spatial immunogenic traits predict efficacy of immunotherapy responses in kidney cancer patients @AbhishekDGarg @NatureMedicine @LisaKinget @snaulrts @Zucmanrossi @MaartenAlbersen oncodaily.com/73004.html #Cancer #OncoDaily #Oncology
2
11
468
Lisa Kinget retweeted
The OncoAlert🚨NEWSLETTER OUT Covering May 17-23 , 2024 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe… Discussing: ✅ICI’s 💉for POLE or POLD1 in met CRC ✅Advancements in mgt of Synchronous CRC Liver Mets ✅5yr outcome w/pembro💉 mono NSCLC🫁 ✅SBRT☢️ in Lung Cancer🫁 ✅RIGHT Choice in #BreastCancer 💊 ✅Selection of Germline Genetic Testing Panels in Patients With Cancer: @ASCO Guidelines ✅A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma ✅Incidence of SLN mets in early #EndometrialCancer ✅Characterization of HER2-low 🧬breast cancer in young women with germline #BRCA 1/2 pathogenetic variants @pashtoonkasi @margheambro1 @FilippoPietran4 @Mom_enji @Areeb_Lutfi @cihangirakyol @Eda_Eylmr_Mcn @StephenVLiu @VamsiVelcheti @HenningWillers @PercyLeeMD @Icro_Meattini @katsuki_arima @StoverLab @FrancescoSche20 @umangtalking @SGreenbergGC @vinay_onc @neerajaiims @Lucarecco @LisaKinget @drenriquegrande @IJGCfellows @JayrajAarthi @IJGConline @matteolambe @BenWestphalen @DrYukselUrun @PGrivasMDPhD #OncoAlertAF @nataliagandur @acampsmalea @MartaPerachino @heinrich_kat @BiagioRicciutMD @DenizCanGuven1 @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @Abdallah81MD @FernandoOnco @ElisaAgostinett @dr_yakupergun @to_be_elizabeth @anmwongNZ
21
20
53
36,425
Spatial HLA signature may predicts response to immunotherapy in advanced renal cell carcinoma. @NatureMedicine @OncoAlert #CancerResearch #oncology #kidney nature.com/articles/s41591-0…
12
36
3,497
⚡️ On @NatureMedicine - A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma #KidneyCancer #Immunotherapy @OncoAlert @OncLive nature.com/articles/s41591-0…
1
14
35
5,482
Multiomics & spatial mapping of tumor samples from patients with advanced #RenalCellCarcinoma, as well as integration of transcriptomic and HLA genotyping data provides a machine learning-derived signature of response to #immune #CheckpointBlockade. nature.com/articles/s41591-0…
12
43
10,738
Incredible work unravelling key features of ICB responsiveness in RCC spearheaded by @LisaKinget @KU_Leuven, out now in @NatureMedicine!
2
10
415